Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain – Vertex Pharmaceuticals

1. Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain  Vertex Pharmaceuticals
2. Vertex Dives On A Pain Drug Mishap, Outweighing Q2 Beat  Investor’s Business Daily
3. Vertex next-generation pain candidate fails Phase 2 trial  statnews.com
4. Vertex to stop developing new painkiller as solo treatment after mid-stage study setback  Reuters
5. Vertex’s experimental pain drug fails main goal in mid-stage study  TradingView

Continue Reading